ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Tetraphase Pharmaceuticals Inc.
2.20
0.0000
成交量:
- -
成交额:
- -
市值:
1,597.91万
市盈率:
-0.17
高:
2.20
开:
2.20
低:
2.20
收:
2.20
数据加载中...
总览
公司
新闻
公告
公司资料
公司名字:
Tetraphase Pharmaceuticals Inc.
交易所:
NASDAQ
成立时间:
- -
员工人数:
- -
公司地址:
- -
官网:
http://www.tphase.com
邮编:
- -
电话:
- -
传真:
- -
简介:
Tetraphase Pharmaceuticals, Inc.依据特拉华州法律于2006年7月7日成立,是一家临床阶段的生物制药公司,利用其专有的化学技术为严重的、威胁生命的、有多种抗药性的感染病的治疗创造新型的抗生素。公司领先的药品替代物eravacycline是一种完全的合成四环素衍生物,将作为首要的偏方单一治疗法发展成一种广泛的静脉注射和口服的抗生素,用于治疗抗多种药物感染病的治疗,包括革兰氏阴性感染病。公司最近为患有复杂腹内感染病(cIAI)患者采用静脉内给药的方式成功完成了eravacycline阶段二的临床试验,目前正在进行关键性的eravacycline阶段三测试。公司期望完成两项全球性的eravacycline阶段三临床试验,一项是对cIAI的治疗试验,另一项是对复杂尿路感染饼(cUTI)的治疗试验。
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/TTPH/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TTPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TTPH\",,,,,undefined,":{"symbol":"TTPH","market":"US","secType":"STK","nameCN":"Tetraphase Pharmaceuticals Inc.","latestPrice":2.2,"timestamp":1595966400000,"preClose":2.2,"halted":4,"volume":0,"delay":0,"floatShares":5033625,"shares":7263236,"eps":-13.306672,"marketStatus":"退市","change":0,"latestTime":"05-21 17:40:16 EDT","open":2.2,"high":2.2,"low":2.2,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-13.306672,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1747872000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1363752000000,"exchange":"NASDAQ","adjPreClose":2.2,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TTPH\",,,,,undefined,":{"symbol":"TTPH","floatShares":5033625,"roa":"-51.46%","roe":"-138.80%","lyrEps":-22.85132,"shares":7263236,"dividePrice":0,"high":2.2,"amplitude":0,"preClose":2.2,"low":2.2,"week52Low":0.56,"pbRate":"0.58","week52High":8.6,"institutionHeld":0,"latestPrice":2.2,"eps":-13.306672,"divideRate":0,"volume":0,"delay":0,"ttmEps":-13.306672,"open":2.2},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.tphase.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":0.1262},{"period":"3month","weight":-0.0328},{"period":"6month","weight":-0.0014},{"period":"1year","weight":0.1185},{"period":"ytd","weight":0.0116}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tetraphase Pharmaceuticals, Inc.依据特拉华州法律于2006年7月7日成立,是一家临床阶段的生物制药公司,利用其专有的化学技术为严重的、威胁生命的、有多种抗药性的感染病的治疗创造新型的抗生素。公司领先的药品替代物eravacycline是一种完全的合成四环素衍生物,将作为首要的偏方单一治疗法发展成一种广泛的静脉注射和口服的抗生素,用于治疗抗多种药物感染病的治疗,包括革兰氏阴性感染病。公司最近为患有复杂腹内感染病(cIAI)患者采用静脉内给药的方式成功完成了eravacycline阶段二的临床试验,目前正在进行关键性的eravacycline阶段三测试。公司期望完成两项全球性的eravacycline阶段三临床试验,一项是对cIAI的治疗试验,另一项是对复杂尿路感染饼(cUTI)的治疗试验。","exchange":"NASDAQ","name":"Tetraphase Pharmaceuticals Inc.","nameEN":"Tetraphase Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"TTPH\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TTPH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-07","symbol":"TTPH","fiscalQuarterEnding":"2020/03","expectedEps":-1.63,"name":null,"time":"","type":"earning","dateTimestamp":1588824000000,"reportTimeType":"","actualEps":-1.31},{"market":"US","date":"2020-03-12","symbol":"TTPH","fiscalQuarterEnding":"2019/12","expectedEps":-5.68,"name":null,"time":"","type":"earning","dateTimestamp":1583985600000,"reportTimeType":"","actualEps":null},{"date":"2019-11-12","symbol":"TTPH","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-6.27,"defaultRemindTime":1573592400000,"name":null,"time":"盘后","dateTimestamp":1573534800000,"actualEps":null},{"market":"US","date":"2019-09-27","symbol":"TTPH","type":"split","dateTimestamp":1569556800000,"forFactor":20,"toFactor":1,"ratio":20},{"date":"2019-08-08","symbol":"TTPH","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-0.38,"defaultRemindTime":1565294400000,"name":null,"time":"盘后","dateTimestamp":1565236800000,"actualEps":-0.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TTPH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TTPH\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TTPH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TTPH","date":"2020-07-28","current":-0.265502,"percent":0.148148,"low":-0.322562,"twenty":-0.24552,"median":-0.163297,"eighty":-0.111312,"high":-0.068361,"avg":-0.171046,"sd":0.066471,"marketCap":16652545},"quantilePoints":[{"date":"2020-05-22","current":-0.305718,"twenty":-0.185507,"median":-0.144231,"eighty":-0.103418,"marketCap":19174943},{"date":"2020-05-29","current":-0.250133,"twenty":-0.187231,"median":-0.147504,"eighty":-0.103719,"marketCap":15688589},{"date":"2020-06-05","current":-0.283716,"twenty":-0.188993,"median":-0.150188,"eighty":-0.105278,"marketCap":17794928},{"date":"2020-06-12","current":-0.271324,"twenty":-0.20078,"median":-0.152962,"eighty":-0.10567,"marketCap":17017732},{"date":"2020-06-19","current":-0.306259,"twenty":-0.204917,"median":-0.153295,"eighty":-0.107179,"marketCap":19208857},{"date":"2020-06-26","current":-0.302765,"twenty":-0.207427,"median":-0.154589,"eighty":-0.108516,"marketCap":18989744},{"date":"2020-07-02","current":-0.286463,"twenty":-0.212936,"median":-0.156518,"eighty":-0.109389,"marketCap":17967220},{"date":"2020-07-10","current":-0.288792,"twenty":-0.220392,"median":-0.158923,"eighty":-0.110037,"marketCap":18113295},{"date":"2020-07-17","current":-0.292285,"twenty":-0.228388,"median":-0.161788,"eighty":-0.110572,"marketCap":18332407},{"date":"2020-07-24","current":-0.265502,"twenty":-0.239407,"median":-0.162726,"eighty":-0.111118,"marketCap":16652545},{"date":"2020-07-28","current":-0.265502,"twenty":-0.24552,"median":-0.163297,"eighty":-0.111312,"marketCap":16652545}],"updateTime":1747833697499}}}